Table 2. NAFLD-Related Costs in Patients With and Without Comorbid Diseases and BMI ≥ 25 (Costs Are Expressed in PPP$).
| Comorbid Diseases | C.Dra | C.M | C.T | C.S | Total Cost |
|---|---|---|---|---|---|
| Without Diseases | 469 | 3548 | 1491 | 138 | 5123 |
| DM | 454 | 2415 | 1458 | 149 | 4222 |
| CAD | 526 | 2880 | 1502 | 129 | 4943 |
| HTN | 497 | 3227 | 1553 | 137 | 5126 |
| HYPO | 472 | 2933 | 1639 | 120 | 4643 |
| BMI ≥ 25 | 482 | 3443 | 1531 | 138 | 5188 |
| Total Cost | 473 | 3348 | 1514 | 138 | 5043 |
aAbbreviation: CAD, coronary artery diseases; C.Dr, cost of physician visits; C.M, cost of medication; C.S, cost of sonography; C.T, cost of laboratory tests; DM, diabetes mellitus; HTN, hypertension; HYPO, hypothyroidism